Latest News
-
HBS Reporting
COVID cases in Asia surpass 100 million – Reuters tally
Mar 30, 2022March 30 (Reuters) – Coronavirus infections in Asia passed 100 million on Wednesday, according to a...
-
HBS Reporting
UK study to test Pfizer’s COVID pill in hospitalised patients
Mar 29, 2022March 28 (Reuters) – Pfizer’s (PFE.N) oral COVID-19 therapy will be evaluated as a potential treatment...
-
HBS Reporting
U.S. FDA approves UCB’s drug for rare childhood epilepsy
Mar 29, 2022March 28 (Reuters) – Belgian biotech firm UCB SA (UCB.BR) said on Monday the U.S. Food...
-
HBS Reporting
Second COVID vaccine booster significantly lowers death rate, Israeli study shows
Mar 29, 2022JERUSALEM, March 27 (Reuters) – Senior citizens who received a second booster of the Pfizer–BioNTech COVID-19...
-
HBS Reporting
Shanghai to lock down in two stages for testing as COVID cases spike
Mar 29, 2022SHANGHAI, March 27 (Reuters) – China’s financial hub of Shanghai said on Sunday it would lock...
-
HBS Reporting
FDA says current dose of GSK-Vir COVID therapy unlikely to work against BA.2 variant
Mar 29, 2022March 25 (Reuters) – The U.S. health regulator said on Friday the current authorized dose of...
-
HBS Reporting
Costs of going unvaccinated in America are mounting for workers and companies
Mar 29, 2022March 25 (Reuters) – Nearly a year after COVID vaccines became freely available in the U.S.,...
-
HBS Reporting
England’s COVID R number remains steady, new infections growing
Mar 29, 2022LONDON, March 25 (Reuters) – The estimated range of England’s COVID-19 reproduction “R” number is between...
-
HBS Reporting
Hong Kong reports 8,841 new daily coronavirus infections
Mar 29, 2022HONG KONG, March 26 (Reuters) – Hong Kong reported 8,841 new cases of COVID-19 on Saturday,...
-
HBS Reporting
Sanctions see Russians panic buy anti-depressants, sleeping pills -data
Mar 29, 2022March 24 (Reuters) – Russians have rushed to stock up on anti-depressants, sleeping pills and contraceptives...